Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 58

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 58
---
 by stockholders.

If the PIPE Financing Proposal is approved and the PIPE Offering is completed, a substantial number of shares of common stock will be restricted from immediate resale but may be sold into the market in the near future. This could cause the market price of our common stock to drop significantly, even if our business is doing well.

Following the consummation of the PIPE Financing, all of the shares of common stock and the shares underlying the Pre-Funded Warrants will
be restricted securities and will not be immediately available for resale. Once we register these shares pursuant to the Registration Rights Agreement, however, they can be freely sold in the public market. As these securities are registered for
resale, the market price of our stock could decline if the holders of currently restricted shares of common stock sell them or are perceived by the market as intending to sell them.

The sale by the PIPE Investors of a significant number of shares of common stock could have a significant negative impact on the market price of our common
stock. In addition, the perception in the public markets that the PIPE Investors may sell all or a portion of the shares issued in the PIPE Financing as a result of the registration of such shares for resale pursuant to the Registration Rights
Agreement could also in and of itself have a material adverse effect on the market price of our common stock. We cannot predict the effect, if any, that market sales of those shares or the availability of those shares for resale will have on the
market price of our common stock. These sales, or the perception in the market that the holders of a large number of shares of common stock intend to sell shares, could reduce the market price of our common stock.

We may become obligated to pay liquidated damages if we fail to file, obtain effectiveness and maintain effectiveness of the registration statement in accordance with the terms of the Subscription Agreement and the form of Registration Rights Agreement related to the PIPE Financing.

In connection
with the PIPE Financing, we granted the PIPE Investors certain resale registration rights pursuant to the terms of the Subscription Agreement and form of Registration Rights Agreement, which will be entered into at the closing of the PIPE Financing.
In addition to the registration rights, the PIPE Investors may be entitled to receive liquidated damages upon the occurrence, or failure to occur, of a number of events relating to the filing, effectiveness and maintenance of effectiveness of a
registration statement related to the common stock and Pre-Funded Warrants sold in the PIPE Financing. The liquidated damages will be payable upon the occurrence, or failure to occur,